By AFP
FRANKFURT: The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the German company said in a statement on Wednesday.
An Omicron-specific version of the jab, currently in development by BioNTech, would be available “by March”, it added.
Last Updated:December 23, 2025, 20:11 ISTSchools closed in Chandauli: चंदौली जिले में बेसिक शिक्षा परिषद के अंतर्गत संचालित…
Hyderabad: The departmental promotion committee (DPC) has proposed the promotion of 53 excise officials, including two joint commissioners,…
NEWYou can now listen to Fox News articles! Airspace over Turkey’s capital was shut down Tuesday night after…
Image Credit: Jayden S. Chien When ROSÉ—the globally recognized K-pop artist and member of BLACKPINK—opened her “rosie” pop-up…
